Literature DB >> 21570138

Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study.

Tatjana S Potpara1, Jelena M Marinkovic, Marija M Polovina, Goran R Stankovic, Petar M Seferovic, Miodrag C Ostojic, Gregory Y H Lip.   

Abstract

BACKGROUND: Several studies have investigated gender-related differences in atrial fibrillation (AF), but limited data are available in relation to gender-related differences in presentation, treatment and long-term outcomes of patients with first-diagnosed AF and structurally normal heart.
OBJECTIVE: To compare gender-related clinical characteristics, presentation, treatment and long-term outcomes in a cohort of patients with first-diagnosed non-valvular AF and a structurally normal heart, following a 10-year follow-up.
METHODS: Observational cohort study of patients with AF between 1992 and 2007.
RESULTS: Of 862 patients (mean age 52.2±12.1 years), 315 (36.5%) were female. Paroxysmal AF and hypertension were significantly more prevalent in females, while persistent AF was more common amongst males (all p<0.001). Female patients were more symptomatic (p=0.002). After a mean follow-up of 10.1±6.1 years, more male patients developed tachycardiomyopathy (6.0% vs. 1.9%, p=0.02). In multivariate analysis, male gender remained significantly associated with tachycardiomyopathy (HR 3.1, 95% CI: 1.3-7.4, p=0.012). The rate of transition to permanent AF, thromboembolism, hemorrhage, all-cause mortality, cardiovascular and sudden death did not significantly differ between male and female patients.
CONCLUSIONS: Gender differences are evident in AF. Male patients were less asymptomatic or more frequently developed persistent AF. Male patients were also at higher risk of tachycardiomyopathy, suggesting that these patients require more attention to rate control during follow-up.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21570138     DOI: 10.1016/j.ijcard.2011.04.022

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

Review 1.  Exercise Testing and Exercise Rehabilitation for Patients With Atrial Fibrillation.

Authors:  Steven J Keteyian; Jonathan K Ehrman; Brittany Fuller; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-03       Impact factor: 2.081

Review 2.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

3.  Gender differences related to the presence of atrial fibrillation in older hypertensive patients.

Authors:  Lorenzo Fácila; Vicente Pallarés; Pedro Morillas; Alberto Cordero; Jose Luis Llisterri; Carlos Sánchis; Jose L Gorriz; Jesus Castillo; Vicente Gil; Josep Redon
Journal:  World J Cardiol       Date:  2013-05-26

4.  Usefulness of the WCD in patients with suspected tachymyopathy.

Authors:  Julia W Erath; Mate Vamos; Alexander P Benz; Stefan H Hohnloser
Journal:  Clin Res Cardiol       Date:  2017-10-09       Impact factor: 5.460

5.  Gender differences in patients with atrial fibrillation.

Authors:  Ralph F Bosch; David Pittrow; Anne Beltzer; Irmtraut Kruck; Wilhelm Kirch; Annette Kohlhaussen; Hendrik Bonnemeier
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-27

6.  Socioeconomic factors and mortality in patients with atrial fibrillation-a cohort study in Swedish primary care.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  Eur J Public Health       Date:  2018-12-01       Impact factor: 3.367

7.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).

Authors:  Christina Magnussen; Teemu J Niiranen; Francisco M Ojeda; Francesco Gianfagna; Stefan Blankenberg; Inger Njølstad; Erkki Vartiainen; Susana Sans; Gerard Pasterkamp; Maria Hughes; Simona Costanzo; Maria Benedetta Donati; Pekka Jousilahti; Allan Linneberg; Tarja Palosaari; Giovanni de Gaetano; Martin Bobak; Hester M den Ruijter; Ellisiv Mathiesen; Torben Jørgensen; Stefan Söderberg; Kari Kuulasmaa; Tanja Zeller; Licia Iacoviello; Veikko Salomaa; Renate B Schnabel
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

8.  Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.

Authors:  Tatjana S Potpara; Marija M Polovina; Nebojsa M Mujovic; Aleksandar M Kocijancic; Gregory Yh Lip
Journal:  Patient Prefer Adherence       Date:  2013-08-26       Impact factor: 2.711

9.  Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation.

Authors:  Yogita M Rochlani; Nishi N Shah; Naga V Pothineni; Hakan Paydak
Journal:  Cardiol Res Pract       Date:  2016-02-07       Impact factor: 1.866

10.  Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.

Authors:  Marcello Disertori; Maria Grazia Franzosi; Simona Barlera; Franco Cosmi; Silvia Quintarelli; Chiara Favero; Glauco Cappellini; Gianna Fabbri; Aldo Pietro Maggioni; Lidia Staszewsky; Luigi Andrea Moroni; Roberto Latini
Journal:  BMC Cardiovasc Disord       Date:  2013-04-15       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.